2026 Regular Session
SB562
State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders
Authorizing licensed certified midwives to enter into therapy management contracts; repealing a requirement that authorized prescribers submit prescriber-pharmacist agreements to the health occupations board that regulates the authorized prescriber; authorizing pharmacists, under certain circumstances, to enter into prescriber-pharmacist agreements that authorize the pharmacist to treat an opioid use disorder using controlled dangerous substances drug therapy; etc.
Legislative progress
i
This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.
Recorded floor votes
2 roll calls are available for this bill. This record includes procedural and intermediate action as well as substantive final votes.
March 12, 2026 · Senate
Third Reading Passed
Passed ⭐ Substantive final action
45 yea–0 nay · 2 absent
April 2, 2026 · House
Third Reading Passed
Passed ⭐ Substantive final action
132 yea–0 nay · 3 not voting · 6 absent
Committee referrals
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
Senate Approved by the Governor - Chapter 54
-
Senate Returned Passed
-
House Third Reading Passed (132-0) View roll call
-
House Favorable Adopted Second Reading Passed
-
House Favorable Report by Health
-
House Hearing 3/25 at 1:00 p.m.
-
House Referred Health
-
Senate Third Reading Passed (45-0) View roll call
-
Senate Second Reading Passed with Amendments
-
Senate Favorable with Amendments {883029/1 Adopted
-
Senate Favorable with Amendments Report by Finance
-
Senate Hearing 3/03 at 1:00 p.m.
-
Senate First Reading Finance